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Abstract: There have been impressive methodological advancements in the
mathematical modelling of cardio-physiological processes. The majority of recent
articles have focused on the forward problem: developing flexible mathematical
models and robust numerical simulation procedures to match characteristics of
physiological target data, and the inverse problem: inferring model parameters
from cardiac physiological data with reliable uncertainty quantification. However,
when connecting mathematical model predictions to the clinical decision process,
new challenges arise. This paper briefly discusses the complications that poten-
tially result from closed-loop e↵ects, and the model extensions that are required
to reduce the ensuing bias.
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1 Introduction and illustration
Consider a random variable X 2 R that represents the value of a clini-
cal disease indicator. Based on some adequate clinical data, which for the
purpose of the following discussion do not need to be made specific, we
monitor its posterior distribution p(x) and the risk of the clinical indicator
exceeding some tolerance threshold




If this risk exceeds some critical value ↵, P (X > ⌧) > ↵, medical treat-
ment, for instance in the form of medication, is provided. While potentially
only aiming at a symptomatic relief, this treatment is assumed to interfere
with the patient’s physiology or pathophysiology and a↵ect the clinical
disease indicator. Let Y 2 Y denote a random variable that represents the
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value of the disease indicator upon medical intervention, and let f describe
the e↵ect of the treatment: y = f(x). This treatment e↵ect implies a









where  (.) is the Dirac delta function. The consequence is a potential pre-
diction bias:
P (Y > ⌧) =
Z 1
⌧
p(y)dy 6= P (X > ⌧) = ↵ (3)
which needs to be accounted for in the clinical decision process. As a simple
illustration, assume the posterior distribution of the clinical indicator prior
to the medical intervention is normal, px(x) = N(x|µ, 2), with mean
µ = 0 and variance  2 = 1, and that the e↵ect of the medical treatment is
a shift of the clinical indicator by  2 R+:
f(x) =
h x if x  ⌧
x   if x > ⌧ (4)
We obtain p(y) by inserting (4) into (2) and making use of the following











where {xi} are the roots of y   f(x) = 0. Inserting (4) and (5) into (2)
gives:
py(y) =
" px(y) if y < ⌧    
px(y) + px(y +  ) if ⌧     y  ⌧
px(y +  ) if y > ⌧
(6)
The apparent probability of the disease indicator to exceed the critical
threshold ⌧ will therefore be evaluated as









N(y|0, 1)dy = G(⌧+ )
where G = 1 G and G(.) is the normal cumulative distribution function,
whereas the actual probability is






N(y|0, 1)dy = G(⌧) (7)
Since G(.) is strictly monotonously decreasing, G(⌧ +  ) < G(⌧), the ap-
parent probability is biased and systematically underestimates the risk of
exceeding the critical threshold ⌧ : P (Y > ⌧) < P (X > ⌧). Hence, by ignor-
ing the e↵ect of the treatment on the clinical indicator variable, any clinical
decision support system based on this indicator variable will systematically
underestimate the patient’s state of risk.
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FIGURE 1. Schematic representation of our physiological model of pulmonary
hypertension and how it is a↵ected by closed-loop e↵ects following a clinical
intervention. See the main text for details.
2 Physiological application: pulmonary hypertension
Pulmonary hypertension, i.e. high blood pressure in the lungs, is a ma-
jor risk factor for a variety of medical conditions, including inadequate
coronary perfusion, stroke and heart failure. Pulmonary blood pressure
can di↵er substantially from blood pressure in the rest of the body (the so-
called systemic circuit) and, as opposed to the latter, can only be measured
invasively. Standard techniques, which are based on right-heart catheter-
ization, can have significant side e↵ects, including internal bleeding and
partial collapse of the lungs.
Recent advances in physiological modelling allow the pulmonary blood
pressure to be predicted from the vasculature geometry and blood flow
times series (Qureshi et al.), which can be measured non-invasively with
computed tomography (CT) and ultrasound, respectively. The biophysical
model depends on various boundary conditions and physiological parame-
ters, most notably the blood vessel sti↵ness, which can be estimated with
computational inference procedures (Paun et al.).
Figure 1 provides a schematic illustration. Given the geometry of the
vasculature, most notably the blood vessel diameters (measured with CT),
the blood flow (measured with ultrasound) and various boundary condi-
tions (obtained from statistical inference, see Qureshi et al.), the model
allows the prediction of the pulmonary blood pressure and the blood vessel
sti↵ness (with the statistical inference techniques described in Paun et al.).
In a clinical application, the prediction of high pulmonary blood pressure
above a critical threshold will trigger the administration of vasodilators,
whose e↵ect is the increase of the vessel diameter. However, as illustrated
4 Closed-loop e↵ects in physiological inference
TABLE 1. Closed-loop e↵ect and its correction in the biophysical modelling of
pulmonary hypertension. Systolic blood flow can be measured with ultrasound;
the initial geometry of the vasculature, including the diastolic diameter of the
main pulmonary artery (MPA), is available from an initial CT scan. The bio-
physical model allows the prediction of the pulmonary systolic blood pressure
(column 1) and the vessel sti↵ness (columns 2-3) with the statistical inference
procedure described in (Paun et al.). The table shows the relative blood vessel
sti↵ness estimation error (median and 95% posterior credible interval) without
(column 2) and with a correction for the closed-loop e↵ect that results from
medical interventions triggered by model predictions (column 3). Since this is a
simulation study (Qureshi et al.), the true vessel sti↵ness is known. Computa-
tional Bayesian inference was carried out with the MCMC scheme described in
Paun et al.
Peak blood pressure Relative error without Relative error with
exceeding threshold closed-loop correction closed-loop correction
25 % 1.51% (1.04%,1.97%) -2.0e-03% (-0.37%,0.37%)
50 % 2.52% (2.15%,2.90%) -1.4e-03% (-0.47%,0.46%)
75 % 61.5% (60.5%,62.4%) -0.26% (-7.78%,6.49%)
in Figure 1, this causes a closed-loop e↵ect, whereby the prediction from the
model causes an action that alters the conditions under which the original
prediction was obtained.
3 Simulation study
Our simulations are based on the pulmonary circulation model described
in Qureshi et al. The blood vessel geometry of the larger blood vessels has
been obtained from a CT scan in a healthy mouse, the e↵ect of the small
terminal blood vessels is approximated with electronic circuit (so-called
Windkessel) elements consisting of two resistances and a capacitance. This
gives three parameters that define downstream boundary conditions of the
partial di↵erential equations (PDEs) describing the blood flow through the
pulmonary circuit. We also assume that the blood flow at the main pul-
monary artery (MPA) is measured (noninvasively with ultrasound), which
provides the upstream boundary condition for the PDEs. Following Qureshi
et al. and Paun et al., we assume the same sti↵ness parameter in all blood
vessels, which adds one further parameter to the physiological model. We
further assume that the blood flows in the two daughter vessels of the MPA
are measured (with ultrasound). Our data used for inference are the time
courses of the blood flows through three blood vessels. The parameters to
be inferred are the vessel sti↵ness and three Windkessel parameters. Once
these parameters have been estimated, the blood pressure in the MPA can
be predicted. A graphical illustration is provided in Figure 2 .
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Measured
blood flow
FIGURE 2. Left panel: 3D smoothed segmented network from a micro-CT image
of a healthy mouse lung. Right panel: Directional graph of the same network.
Blood flow waveforms are taken from ultrasound measurements at the main pul-
monary artery (MPA) and two daughter vessels. At the outlet of each terminal
vessel, three-element Windkessel elements with two resistors and a capacitor are
attached as boundary conditions to mimic the e↵ect of the microvasculature fur-
ther downstream.
To simulate the e↵ect of clinical interventions, we monitor the blood
pressure in the MPA, and provide an in-silico vasodilator whenever the
pressure exceeds a critical threshold. Since this is a proof-of-concept study,
we use data from mice rather than humans, and set as an arbitrary thresh-
old the peak pressure found in the hypoxic control mice used in the study
of Qureshi et al. We simulate the e↵ect of the vasodilator by increasing
the diastolic trough diameter of all blood vessels by the same percentage
amount, whose value is determined by the requirement that upon medi-
cal intervention, the peak blood pressure in the MPA must not exceed the
critical value by more than 5%. This bandwidth defines the uncertainty
that remains when explicitly including the closed-loop e↵ect caused by the
medical intervention in the model. We compare that with naive parameter
inference that does not include any correction for the medical intervention,
and assumes the diastolic blood vessel diameter to be fixed. We quantify
the e↵ect of ignoring the feedback loop with the percentage estimation error
of the vessel sti↵ness.
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4 Results
The results can be found in Table 1. They demonstrate that ignoring the
closed-loop e↵ect leads to a systematic bias in the estimation of the blood
vessel sti↵ness, which is a critical risk indicator for vessel wall rupture,
stroke and right-ventricle heart failure (Chen et al). Allowing for the med-
ical intervention and including the ensuing feedback loop in the statistical
inference corrects this bias and leads to a substantially improved estimation
of the sti↵ness parameter.
5 Conclusions
Quantitative physiological models have great potential for improved and
automated clinical decision support. However, it is important to correct for
closed-loop e↵ects in model calibration. Using a mathematical toy problem
and a realistic fluid dynamics simulation of the pulmonary blood circula-
tion system, we have shown that failing to allow for the e↵ect of medical
interventions – and not explicitly including them in the model – can lead
to a systematic prediction bias. Our future work will focus on improved
statistical inference when data on the e↵ect of medical interventions are
noisy and/or partially missing.
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